Annual Working Capital
$128.98 M
+$20.21 M+18.58%
December 1, 2024
Summary
- As of March 10, 2025, TBPH annual working capital is $128.98 million, with the most recent change of +$20.21 million (+18.58%) on December 1, 2024.
- During the last 3 years, TBPH annual working capital has fallen by -$62.30 million (-32.57%).
- TBPH annual working capital is now -73.09% below its all-time high of $479.24 million, reached on December 31, 2016.
Performance
TBPH Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$128.98 M
+$35.94 M+38.62%
December 1, 2024
Summary
- As of March 10, 2025, TBPH quarterly working capital is $128.98 million, with the most recent change of +$35.94 million (+38.62%) on December 1, 2024.
- Over the past year, TBPH quarterly working capital has stayed the same.
- TBPH quarterly working capital is now -73.09% below its all-time high of $479.24 million, reached on December 31, 2016.
Performance
TBPH Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
TBPH Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +18.6% | 0.0% |
| 3 y3 years | -32.6% | 0.0% |
| 5 y5 years | -43.1% | 0.0% |
TBPH Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -60.3% | +18.6% | -65.1% | +38.6% |
| 5 y | 5-year | -60.3% | +18.6% | -70.4% | +38.6% |
| alltime | all time | -73.1% | +667.0% | -73.1% | +662.2% |
Theravance Biopharma Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $128.98 M(+18.6%) | $128.98 M(+38.6%) |
| Sep 2024 | - | $93.05 M(-3.4%) |
| Jun 2024 | - | $96.36 M(-6.1%) |
| Mar 2024 | - | $102.63 M(-5.6%) |
| Dec 2023 | $108.77 M(-66.5%) | $108.77 M(-20.2%) |
| Sep 2023 | - | $136.32 M(-18.6%) |
| Jun 2023 | - | $167.46 M(-28.8%) |
| Mar 2023 | - | $235.15 M(-27.6%) |
| Dec 2022 | $324.75 M(+69.8%) | $324.75 M(-12.1%) |
| Sep 2022 | - | $369.59 M(+202.7%) |
| Jun 2022 | - | $122.11 M(-23.9%) |
| Mar 2022 | - | $160.44 M(-16.1%) |
| Dec 2021 | $191.28 M(-29.1%) | $191.28 M(-17.2%) |
| Sep 2021 | - | $231.09 M(-13.1%) |
| Jun 2021 | - | $266.05 M(+28.8%) |
| Mar 2021 | - | $206.58 M(-23.4%) |
| Dec 2020 | $269.77 M(+19.0%) | $269.77 M(-22.1%) |
| Sep 2020 | - | $346.45 M(-11.6%) |
| Jun 2020 | - | $391.81 M(-10.2%) |
| Mar 2020 | - | $436.18 M(+92.3%) |
| Dec 2019 | $226.78 M | $226.78 M(-8.1%) |
| Sep 2019 | - | $246.83 M(-21.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $315.90 M(-10.7%) |
| Mar 2019 | - | $353.69 M(-18.6%) |
| Dec 2018 | $434.27 M(+37.3%) | $434.27 M(+88.3%) |
| Sep 2018 | - | $230.58 M(-21.4%) |
| Jun 2018 | - | $293.21 M(-14.2%) |
| Mar 2018 | - | $341.64 M(+8.0%) |
| Dec 2017 | $316.20 M(-34.0%) | $316.20 M(-0.7%) |
| Sep 2017 | - | $318.35 M(-2.9%) |
| Jun 2017 | - | $327.78 M(-12.0%) |
| Mar 2017 | - | $372.52 M(-22.3%) |
| Dec 2016 | $479.24 M(+154.9%) | $479.24 M(+109.6%) |
| Sep 2016 | - | $228.63 M(-11.5%) |
| Jun 2016 | - | $258.47 M(+34.4%) |
| Mar 2016 | - | $192.35 M(+2.3%) |
| Dec 2015 | $188.00 M(-19.7%) | $188.00 M(-10.8%) |
| Sep 2015 | - | $210.81 M(-10.6%) |
| Jun 2015 | - | $235.75 M(-4.4%) |
| Mar 2015 | - | $246.70 M(+5.4%) |
| Dec 2014 | $234.11 M(-1129.2%) | $234.11 M(-13.6%) |
| Sep 2014 | - | $270.88 M(-20.9%) |
| Jun 2014 | - | $342.62 M(-1593.3%) |
| Mar 2014 | - | -$22.94 M(+0.9%) |
| Dec 2013 | -$22.75 M | -$22.75 M |
FAQ
- What is Theravance Biopharma annual working capital?
- What is the all time high annual working capital for Theravance Biopharma?
- What is Theravance Biopharma annual working capital year-on-year change?
- What is Theravance Biopharma quarterly working capital?
- What is the all time high quarterly working capital for Theravance Biopharma?
- What is Theravance Biopharma quarterly working capital year-on-year change?
What is Theravance Biopharma annual working capital?
The current annual working capital of TBPH is $128.98 M
What is the all time high annual working capital for Theravance Biopharma?
Theravance Biopharma all-time high annual working capital is $479.24 M
What is Theravance Biopharma annual working capital year-on-year change?
Over the past year, TBPH annual working capital has changed by +$20.21 M (+18.58%)
What is Theravance Biopharma quarterly working capital?
The current quarterly working capital of TBPH is $128.98 M
What is the all time high quarterly working capital for Theravance Biopharma?
Theravance Biopharma all-time high quarterly working capital is $479.24 M
What is Theravance Biopharma quarterly working capital year-on-year change?
Over the past year, TBPH quarterly working capital has changed by $0.00 (0.00%)